Syntone Ventures LLC

Average Profitability
28.25%
Insider Buys Quantity
3
Insider Buys Sum
$10M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Syntone Ventures LLC

According to the SEC Form 4 filings, Syntone Ventures LLC, being in a position of

  1. 10 percent owner at Outlook Therapeutics, Inc.,
    оver the last 12 months, has bought 714286 shares for $5M, and sold 0 shares,
    over all time since 2020-07-15, has bought 5360376 shares for $10M, and sold 0 shares.

The largest purchase of all time was on 2024-04-15 and amounted to 714286 shares of Outlook Therapeutics, Inc. for $5M.

Biography of Syntone Ventures LLC

No biography is available at this moment.

2024-04-15PurchaseOutlook Therapeutics, Inc.
OTLK
10 percent owner
714,286
2.6874%
$7.00$5M-14.5%
2021-02-03PurchaseOutlook Therapeutics, Inc.
OTLK
10 percent owner
3M
1.354%
$1.00$3M+50.34%
2020-07-15PurchaseOutlook Therapeutics, Inc.
OTLK
10 percent owner
1.65M
1.5969%
$1.22$2M+6.16%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.